The Impact of Different Anesthetics on the Distribution and Cytotoxic Function of NK Cell Subpopulations: An In Vitro Study

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2024 Oct 26

PMID 39456827

Authors

Tristan J Vulcano

Wayel H Abdulahad

Matijs van Meurs

Rianne M Jongman

Michel M R F Struys

Dirk J Bosch

Affiliations

Soon will be listed here.

Abstract

Only some subpopulations of natural killer (NK) cells have cytotoxic functionality, and the effects of anesthetics on these subpopulations are unknown. This study aimed to evaluate the in vitro effects of various anesthetics, both alone and in combination, on the distribution and cytotoxic function of NK cells and their subpopulations. Peripheral blood mononuclear cells (PBMCs) from eight healthy volunteers were treated for 4 h in vitro with dexmedetomidine, remifentanil, lidocaine, propofol, sevoflurane, and combinations in clinically relevant concentrations or left untreated. Flow cytometry was used to quantify the percentage of sampled NK cells and evaluate their distribution (CD56CD16, CD56CD16, CD56CD16, CD56CD16, and CD56CD16) and cytotoxicity (Granzyme B (GrzB) and perforin) of NK cell subpopulations. Although the percentage of total NK cells did not change following exposure to anesthesia, the most important cytotoxic subpopulation (CD56CD16 NK cells) decreased after exposure to both propofol (-3.58%, = 0.045) and sevoflurane (-16.10%, = 0.008) alone, and most combinations, especially in combination with lidocaine (propofol with lidocaine (-9.66%, = 0.002) and sevoflurane with lidocaine (-21.90%, < 0.001)). Dexmedetomidine and remifentanil had no effect on CD56CD16 NK cells. Furthermore, no anesthetic regimen or combination altered the expression of GrzB and perforin in NK cells or NK cell subpopulations. In short, propofol and sevoflurane suppressed the highly cytotoxic phenotype (CD56CD16) of NK cells, with those exposed to sevoflurane combinations showing greater reductions. Immunosuppression was intensified with the inclusion of lidocaine in the anesthetic regimen.

References

Yap A, Lopez-Olivo M, Dubowitz J, Hiller J, Riedel B . Anesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia. Can J Anaesth. 2019; 66(5):546-561. DOI: 10.1007/s12630-019-01330-x. View

Wang K, Wu M, Xu J, Wu C, Zhang B, Wang G . Effects of dexmedetomidine on perioperative stress, inflammation, and immune function: systematic review and meta-analysis. Br J Anaesth. 2019; 123(6):777-794. DOI: 10.1016/j.bja.2019.07.027. View

Sacerdote P, Gaspani L, Rossoni G, Panerai A, Bianchi M . Effect of the opioid remifentanil on cellular immune response in the rat. Int Immunopharmacol. 2001; 1(4):713-9. DOI: 10.1016/s1567-5769(01)00005-4. View

Gonzalez H, Hagerling C, Werb Z . Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes Dev. 2018; 32(19-20):1267-1284. PMC: 6169832. DOI: 10.1101/gad.314617.118. View

Cronin A, Aucutt-Walter N, Budinetz T, Bonafide C, DiVittore N, Gordin V . Low-dose remifentanil infusion does not impair natural killer cell function in healthy volunteers. Br J Anaesth. 2003; 91(6):805-9. DOI: 10.1093/bja/aeg273. View

Lim J, Oh C, Yoon T, Lee J, Lee S, Yoo Y . The effect of propofol and sevoflurane on cancer cell, natural killer cell, and cytotoxic T lymphocyte function in patients undergoing breast cancer surgery: an in vitro analysis. BMC Cancer. 2018; 18(1):159. PMC: 5803927. DOI: 10.1186/s12885-018-4064-8. View

Buckley A, McQuaid S, Johnson P, Buggy D . Effect of anaesthetic technique on the natural killer cell anti-tumour activity of serum from women undergoing breast cancer surgery: a pilot study. Br J Anaesth. 2014; 113 Suppl 1:i56-62. DOI: 10.1093/bja/aeu200. View

Cata J, Ramirez M, Velasquez J, Di A, Popat K, Gottumukkala V . Lidocaine Stimulates the Function of Natural Killer Cells in Different Experimental Settings. Anticancer Res. 2017; 37(9):4727-4732. DOI: 10.21873/anticanres.11879. View

Mitsuhata H, Shimizu R, Yokoyama M . Suppressive effects of volatile anesthetics on cytokine release in human peripheral blood mononuclear cells. Int J Immunopharmacol. 1995; 17(6):529-34. DOI: 10.1016/0192-0561(95)00026-x. View

10.

Schneemilch C, Hachenberg T, Ansorge S, Ittenson A, Bank U . Effects of different anaesthetic agents on immune cell function in vitro. Eur J Anaesthesiol. 2005; 22(8):616-23. DOI: 10.1017/s0265021505001031. View

11.

Chang C, Wu M, Chien Y, Su I, Wang S, Kao M . Anesthesia and Long-term Oncological Outcomes: A Systematic Review and Meta-analysis. Anesth Analg. 2020; 132(3):623-634. DOI: 10.1213/ANE.0000000000005237. View

12.

Wall T, Sherwin A, Ma D, Buggy D . Influence of perioperative anaesthetic and analgesic interventions on oncological outcomes: a narrative review. Br J Anaesth. 2019; 123(2):135-150. PMC: 6676329. DOI: 10.1016/j.bja.2019.04.062. View

13.

Ramirez M, Tran P, Cata J . The effect of clinically therapeutic plasma concentrations of lidocaine on natural killer cell cytotoxicity. Reg Anesth Pain Med. 2014; 40(1):43-8. DOI: 10.1097/AAP.0000000000000191. View

14.

Oh C, Park H, Piao L, Sohn K, Koh S, Hwang D . Expression Profiles of Immune Cells after Propofol or Sevoflurane Anesthesia for Colorectal Cancer Surgery: A Prospective Double-blind Randomized Trial. Anesthesiology. 2022; 136(3):448-458. DOI: 10.1097/ALN.0000000000004119. View

15.

Melamed R, Bar-Yosef S, Shakhar G, Shakhar K, Ben-Eliyahu S . Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth Analg. 2003; 97(5):1331-1339. DOI: 10.1213/01.ANE.0000082995.44040.07. View

16.

Li R, Mukherjee M, Jin Z, Liu H, Lin K, Liu Q . The Potential Effect of General Anesthetics in Cancer Surgery: Meta-Analysis of Postoperative Metastasis and Inflammatory Cytokines. Cancers (Basel). 2023; 15(10). PMC: 10216624. DOI: 10.3390/cancers15102759. View

17.

Tazawa K, Koutsogiannaki S, Chamberlain M, Yuki K . The effect of different anesthetics on tumor cytotoxicity by natural killer cells. Toxicol Lett. 2016; 266:23-31. PMC: 5209272. DOI: 10.1016/j.toxlet.2016.12.007. View

18.

Salagianni M, Baxevanis C, Papamichail M, Perez S . New insights into the role of NK cells in cancer immunotherapy. Oncoimmunology. 2012; 1(2):205-207. PMC: 3376993. DOI: 10.4161/onci.1.2.18398. View

19.

Cassinello F, Prieto I, Del Olmo M, Rivas S, Strichartz G . Cancer surgery: how may anesthesia influence outcome?. J Clin Anesth. 2015; 27(3):262-72. DOI: 10.1016/j.jclinane.2015.02.007. View

20.

Chan I, Ewald A . The changing role of natural killer cells in cancer metastasis. J Clin Invest. 2022; 132(6). PMC: 8920322. DOI: 10.1172/JCI143762. View